Annual Accounts Receivable
$1.31 M
-$29.80 K-2.22%
March 31, 2024
Summary
- As of February 25, 2025, SXTC annual accounts receivable is $1.31 million, with the most recent change of -$29.80 thousand (-2.22%) on March 31, 2024.
- During the last 3 years, SXTC annual accounts receivable has fallen by -$3.19 million (-70.83%).
- SXTC annual accounts receivable is now -70.83% below its all-time high of $4.51 million, reached on March 31, 2021.
Performance
SXTC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.31 M
+$3800.00+0.29%
March 31, 2024
Summary
- As of February 25, 2025, SXTC quarterly accounts receivable is $1.31 million, with the most recent change of +$3800.00 (+0.29%) on March 31, 2024.
- Over the past year, SXTC quarterly accounts receivable has stayed the same.
- SXTC quarterly accounts receivable is now -76.44% below its all-time high of $5.58 million, reached on September 30, 2020.
Performance
SXTC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SXTC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | 0.0% |
| 3 y3 years | -70.8% | 0.0% |
| 5 y5 years | -68.5% | 0.0% |
SXTC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.8% | at low | -66.1% | +0.3% |
| 5 y | 5-year | -70.8% | at low | -76.4% | +0.3% |
| alltime | all time | -70.8% | at low | -76.4% | +0.3% |
China SXT Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $1.31 M(-2.2%) | $1.31 M(+0.3%) |
| Sep 2023 | - | $1.31 M(-2.5%) |
| Mar 2023 | $1.34 M(-59.7%) | $1.34 M(-59.5%) |
| Sep 2022 | - | $3.32 M(-0.3%) |
| Mar 2022 | $3.33 M(-26.0%) | $3.33 M(-14.2%) |
| Sep 2021 | - | $3.88 M(-13.9%) |
| Mar 2021 | $4.51 M | $4.51 M(-19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $5.58 M(+46.1%) |
| Mar 2020 | $3.82 M(-8.6%) | $3.82 M(-16.4%) |
| Sep 2019 | - | $4.57 M(+9.3%) |
| Mar 2019 | $4.18 M(+60.6%) | $4.18 M(+7.5%) |
| Sep 2018 | - | $3.89 M(+49.5%) |
| Mar 2018 | $2.60 M(-5.1%) | $2.60 M |
| Mar 2017 | $2.74 M | - |
FAQ
- What is China SXT Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual accounts receivable year-on-year change?
- What is China SXT Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals quarterly accounts receivable year-on-year change?
What is China SXT Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of SXTC is $1.31 M
What is the all time high annual accounts receivable for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual accounts receivable is $4.51 M
What is China SXT Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, SXTC annual accounts receivable has changed by -$29.80 K (-2.22%)
What is China SXT Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of SXTC is $1.31 M
What is the all time high quarterly accounts receivable for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high quarterly accounts receivable is $5.58 M
What is China SXT Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, SXTC quarterly accounts receivable has changed by $0.00 (0.00%)